母亲神经发育风险等位基因与早期生活暴露的关联
基于ALSPAC队列7921名母亲的研究,检验母亲ADHD、ASD和SCZ多基因风险评分(PRS)与32项早期生活暴露的关联。结果显示母亲ADHD PRS与多种产前因素相关,而ASD PRS或SCZ PRS与产前因素关联证据不足,且任何PRS均与不良出生事件无显著关联。
要点
- 母亲ADHD PRS与感染、孕晚期使用对乙酰氨基酚、较低血汞和较高血镉水平相关。
- ASD PRS或SCZ PRS与产前因素关联证据不足,任何PRS与不良出生事件无关。
- 评估产前暴露对子代神经发育障碍的影响时需考虑遗传混杂。
核心结论
- 母亲神经发育障碍风险等位基因(主要是ADHD)与部分妊娠相关暴露相关。
- 这些发现提示评估产前暴露对子代神经发育障碍的影响时需仔细考虑潜在遗传混杂。
研究设计与样本
- 英国基于人群的队列研究,纳入Avon亲子纵向研究(ALSPAC)中有基因型的7921名母亲。
- 计算母亲ADHD、ASD和SCZ多基因风险评分(PRS),检验其与32项早期生活暴露的关联。
主要发现
- 母亲ADHD PRS与感染(OR 1.11,95%CI 1.04-1.18)和孕晚期使用对乙酰氨基酚(OR 1.11,95%CI 1.04-1.18)相关。
- 母亲ADHD PRS与较低血汞水平(β=-0.06,95%CI -0.11至-0.02)和较高血镉水平(β=0.07,95%CI 0.05-0.09)相关。
- ASD PRS或SCZ PRS与产前因素关联证据不足,任何PRS与不良出生事件无显著关联。
关键数值与推荐
- 母亲PRS计算使用最大可用全基因组关联研究的发现效应量估计,显著性阈值P<.05。
临床怎么用
- 在评估产前暴露与子代神经发育障碍的因果关联时,应考虑母亲遗传因素可能造成的混杂。
- 建议采用三角互证方法整合不同研究设计证据以加强因果推断。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Early-life exposures, such as prenatal maternal lifestyle, illnesses, nutritional deficiencies, toxin levels, and adverse birth events, have long been considered potential risk factors for neurodevelopmental disorders in offspring. However, maternal genetic factors could be confounding the association between early-life exposures and neurodevelopmental outcomes in offspring, which makes inferring a causal relationship problematic. OBJECTIVE: To test whether maternal polygenic risk scores (PRSs) for neurodevelopmental disorders were associated with early-life exposures previously linked to the disorders. DESIGN, SETTING, AND PARTICIPANTS: In this UK population-based cohort study, 7921 mothers with genotype data from the Avon Longitudinal Study of Parents and Children (ALSPAC) underwent testing for association of maternal PRS for attention-deficit/hyperactivity disorder (ADHD PRS), autism spectrum disorder (ASD PRS), and schizophrenia (SCZ PRS) with 32 early-life exposures. ALSPAC data collection began September 6, 1990, and is ongoing. Data were analyzed for the current study from April 1 to September 1, 2018. EXPOSURES: Maternal ADHD PRS, ASD PRS, and SCZ PRS were calculated using discovery effect size estimates from the largest available genome-wide association study and a significance threshold of P < .05. MAIN OUTCOMES AND MEASURES: Outcomes measured included questionnaire data on maternal lifestyle and behavior (eg, smoking, alcohol consumption, body mass index, and maternal age), maternal use of nutritional supplements and medications in pregnancy (eg, acetaminophen, iron, zinc, folic acid, and vitamins), maternal illnesses (eg, diabetes, hypertension, rheumatism, psoriasis, and depression), and perinatal factors (eg, birth weight, preterm birth, and cesarean delivery). RESULTS: Maternal PRSs were available from 7921 mothers (mean [SD] age, 28.5 [4.8] years). The ADHD PRS was associated with multiple prenatal factors, including infections (odds ratio [OR], 1.11; 95% CI, 1.04-1.18), use of acetaminophen during late pregnancy (OR, 1.11; 95% CI, 1.04-1.18), lower blood levels of mercury (β coefficient, -0.06; 95% CI, -0.11 to -0.02), and higher blood levels of cadmium (β coefficient, 0.07; 95% CI, 0.05-0.09). Little evidence of associations between ASD PRS or SCZ PRS and prenatal factors or of association between any of the PRSs and adverse birth events was found. Sensitivity analyses revealed consistent results. CONCLUSIONS AND RELEVANCE: These findings suggest that maternal risk alleles for neurodevelopmental disorders, primarily ADHD, are associated with some pregnancy-related exposures. These findings highlight the need to carefully account for potential genetic confounding and triangulate evidence from different approaches when assessing the effects of prenatal exposures on neurodevelopmental disorders in offspring.
引用
- Leppert B, Havdahl A, Riglin L, et al. Association of Maternal Neurodevelopmental Risk Alleles With Early-Life Exposures. JAMA Psychiatry. 2019. PMID: 31042271. doi:10.1001/jamapsychiatry.2019.0774
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。